Related Experiment Video
Updated: Mar 28, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia
Wei-Na Jin1, Xiaoxia Yang2, Zhiguo Li3
1Departments of Neurology, Immunology, Radiology, Key Laboratory of Neurorepair and Regeneration, Tianjin and Ministry of Education, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Insights
Researchers developed a novel in vivo imaging method to track CD4(+) T cells in experimental ischemic stroke. This technique allows for non-invasive monitoring of these crucial immune cells in the brain and peripheral organs.
Area of Science:
- Neuroscience
- Immunology
- Medical Imaging
Background:
- Lymphocytes are critical in ischemic brain injury.
- Non-invasive tracking of lymphocytes in the inflamed central nervous system (CNS) remains challenging.
- Understanding lymphocyte dynamics is key to developing new therapies for CNS inflammatory diseases.
Purpose of the Study:
- To develop and validate an in vivo imaging approach for sequential monitoring of CD4(+) T cells in experimental ischemic stroke.
- To assess the feasibility of using magnetic resonance imaging (MRI) or Xenogen imaging combined with SPIO-Molday ION Rhodamine-B (MIRB) labeling for tracking these cells.
- To investigate the spatiotemporal dynamics of brain-infiltrating CD4(+) T cells.
Main Methods:
- Labeling of CD4(+) T cells with SPIO-Molday ION Rhodamine-B (MIRB).
- In vivo imaging using MRI or Xenogen imaging for longitudinal monitoring.
- Passive transfer model in experimental ischemic stroke.
- Immunostaining of tissue sections for validation.
Main Results:
- MIRB-labeled CD4(+) T cells were successfully visualized in the mouse brain using in vivo imaging.
- Longitudinal monitoring revealed the dynamics of CD4(+) T cells in the brain, spleen, and liver after cerebral ischemia.
- In vivo observations correlated well with ex vivo immunostaining data, confirming the accuracy of the tracking method.
Conclusions:
- The combination of MIRB labeling and in vivo imaging provides a valid method for tracking CD4(+) T cells in ischemic brain injury.
- This approach enables the study of spatiotemporal dynamics of brain-infiltrating lymphocytes in CNS inflammatory conditions.
- Facilitates future research into the role of lymphocytes in neurological diseases.
Abstract:
Recent studies have demonstrated that lymphocytes play a key role in ischemic brain injury. However, there is still a lack of viable approaches to non-invasively track infiltrating lymphocytes and reveal their key spatiotemporal events in the inflamed central nervous system (CNS). Here we describe an in vivo imaging approach for sequential monitoring of brain-infiltrating CD4(+) T cells in experimental ischemic stroke. We show that magnetic resonance imaging (MRI) or Xenogen imaging combined with labeling of SPIO-Molday ION Rhodamine-B (MIRB) can be used to monitor the dynamics of CD4(+) T cells in a passive transfer model. MIRB-labeled CD4(+) T cells can be longitudinally visualized in the mouse brain and peripheral organs such as the spleen and liver after cerebral ischemia. Immunostaining of tissue sections showed similar kinetics of MIRB-labeled CD4(+) T cells when compared with in vivo observations. Our results demonstrated the use of MIRB coupled with in vivo imaging as a valid method to track CD4(+) T cells in ischemic brain injury. This approach will facilitate future investigations to identify the dynamics and key spatiotemporal events for brain-infiltrating lymphocytes in CNS inflammatory diseases.
More Related Videos
10:03Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
Published on: November 21, 2019
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024